As of Apr 17
| -0.03 / -0.75%|
The 2 analysts offering 12-month price forecasts for VolitionRX Ltd have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +102.02% increase from the last price of 3.96.
The current consensus among 2 polled investment analysts is to Buy stock in VolitionRX Ltd. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.